GlobeNewswire Inc.··Not SpecifiedSatellos Bioscience to Present SAT-3247 Program at Major Investor Conferences
Satellos Bioscience to present SAT-3247 clinical progress at Jefferies and Oppenheimer conferences in June 2026, with BASECAMP trial enrollment on track for Q3 completion.
MSLEclinical-stageinvestor conference